At the virtual San Antonio Breast Cancer Symposium, researchers presented 12-year results for tamoxifen versus anastrozole [Arimidex], which demonstrated no significant difference in terms of disease ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) today announced its first-ever direct-to-patient program offering patients with a valid prescription for ARIMIDEX or anastrozole the ...

June 6, 2007 (Chicago) — One of the worst adverse effects of treatment with aromatase inhibitors in breast cancer — drug-induced bone loss of around 2% each year — can be prevented by the use of a ...

SAN ANTONIO — Anastrozole reduced breast cancer risk by 49% compared with placebo for postmenopausal women at high risk for the disease, according to long-term results of the randomized controlled ...

AstraZeneca (NYSE: AZN) today launched new digital resources to educate patients on how to enroll in . Resources include a outlining the enrollment process for ARIMIDEX and a that can be shared via ...

Researchers find that women with postmenopausal hormone receptor (HR)-positive breast cancer may undergo shorter treatments of Arimidex, which may in turn cause less bone fractures. Researchers find ...

CHICAGO, Dec 14 (Reuters) - Women who took AstraZeneca Plc's breast cancer drug Arimidex fared better than those who took the pill tamoxifen even four years after they stopped taking it, researchers ...

Share on Pinterest Anastrozole can reduce breast cancer risk after menopause, but does it come with its own risks? Image credit: shironosov/Getty Images. A drug used as a breast cancer treatment has ...

Waldenström's macroglobulinemia is a lymphoproliferative disorder characterized by a lymphoplasmacytic bone marrow infiltrate and high levels of a monoclonal IgM in serum. 1 A number of ...

A drug used to treat and prevent breast cancer, Arimidex, can significantly reduce the pain of endometriosis when taken daily along with an oral contraceptive, investigators in the U.S. report.

Post-menopausal women in the UK who are at a higher risk of breast cancer may soon have wider access to a medicine called anastrozole to reduce their chance of developing it. The drug, which is taken ...